Pfizer expects $20 billion in COVID-19 vaccine sales in 2021

The coronavirus pandemic is really paying off for Pfizer, which expects to rake in about $US15 billion ($A19.65 billion) from its coronavirus vaccine this year – about a quarter of its entire projected 2021 revenue.


The drug, developed with German partner BioNTech, has a profit margin of more than 20 per cent, the company said.


https://www.news.com.au/finance/business/manufacturing/pfizer-expects-20-billion-in-covid19-vaccine-sales-in-2021/news-story/eb0280052d5e479c56a4d4376d74568e